Drug Shortage Report for SHINGRIX
| Report ID | 226055 |
| Drug Identification Number | 02468425 |
| Brand name | SHINGRIX |
| Common or Proper name | Herpes Zoster vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN |
| Strength(s) | 50MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10s |
| ATC code | J07BK |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-04-19 |
| Estimated end date | 2024-08-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-25 |
| Company comments | Supply of 10-pack is available for public programs. Supply of 10-pack is unavailable for the private market. SHINGRIX packages of 1 are available to order for both the public and private market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-04-25 | French | Compare |
| v3 | 2024-04-25 | English | Compare |
| v2 | 2024-04-24 | French | Compare |
| v1 | 2024-04-24 | English | Compare |
Showing 1 to 4 of 4